EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endobronchial Ultrasound Guided Transbronchial Needle Aspiration and PD-L1 Yields

Lara M Khoury iD, Kristin N Sheehan, William I Mariencheck, Katherine A Gershner, Matthew Maslonka, Angela G Niehaus, Scott Isom, Christina R Bellinger

Lung · 2024

DOI: 10.1007/s00408-024-00692-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lung, 2024. Verfasst von Lara M Khoury und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA. lkhoury@wakehealth.edu. Hauptthemen laut MEDLINE: Lung Neoplasms, B7-H1 Antigen, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Wake Forest University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Immunotherapy is a leading approach for treating advanced non-small cell lung cancer (NSCLC) by targeting the PD-1/PD-L1 checkpoint signaling pathway, particularly in tumors expressing high levels of PD-L1 (Jug et al. in J Am Soc Cytopathol 9:485–493, 2020; Perrotta et al. in Chest 158: 1230–1239, 2020). Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive method to obtain tissue for molecular studies, including PD-L1 analysis, in unresectable tumors (Genova et al. in Front Immunol 12: 799455, 2021; Wang et al. in Ann Oncol 29: 1417–1422, 2018). This study aimed to assess the adequacy of PD-L1 assessment in EBUS-TBNA cytology specimens.

Methods

Data was collected retrospectively from patients who underwent EBUS-TBNA between 2017 and 2021 for suspected lung cancer biopsy. Samples positive for NSCLC were examined for PD-L1 expression. EBUS was performed by experienced practitioners, following institutional guidelines of a minimum of five aspirations from positively identified lesions. Sample adequacy for molecular testing was determined by the pathology department.

Results

The analysis involved 387 NSCLC cases (149 squamous cell, 191 adenocarcinoma, 47 unspecified). Of the 263 EBUS-TBNA specimens tested for PD-L1, 237 (90.1%) were deemed adequate. While 84% adhered to the protocol, adherence did not yield better results. Significantly higher PD-L1 adequacy was observed in squamous cell carcinomas (93.2%) compared to adenocarcinoma (87.6%). The number of aspirations and sedation type did not correlate with PD-L1 adequacy in either cancer type, but lesion size and location had a significant impact in adenocarcinomas. Adenocarcinoma exhibited higher PD-L1 expression (68%) compared to squamous cell carcinoma (48%).

Conclusion

EBUS-TBNA offers high yields for assessing immunotherapy markers like PD-L1, with satisfactory adequacy regardless of NSCLC subtype, lesion size, or location.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsB7-H1 AntigenEndoscopic Ultrasound-Guided Fine Needle AspirationCarcinoma, Non-Small-Cell LungHumansMaleRetrospective StudiesFemaleAgedMiddle AgedAdenocarcinoma of LungAged, 80 and overAdultBronchoscopyAdenocarcinoma

Stichwörter der Autor:innen

BronchoscopyEBUS-TBNALung cancerMolecular markersPD-L1 yields

Substanzen

B7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA. lkhoury@wakehealth.edu.
  • Department of Pulmonary and Critical Care Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Department of Pulmonary and Critical Care Medicine, Nebraska Pulmonary Specialties, Lincoln, NE, USA.
  • Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

ORCID-Profile: Lara M Khoury

Förderung

  • NCI NIH HHS
  • Wake Forest University

Zitieren

APA

Khoury, L. M., Sheehan, K. N., Mariencheck, W. I., Gershner, K. A., Maslonka, M., Niehaus, A. G., Isom, S., & Bellinger, C. R. (2024). Endobronchial Ultrasound Guided Transbronchial Needle Aspiration and PD-L1 Yields. Lung. https://doi.org/10.1007/s00408-024-00692-4

Vancouver

Khoury LM, Sheehan KN, Mariencheck WI, Gershner KA, Maslonka M, Niehaus AG, et al. Endobronchial Ultrasound Guided Transbronchial Needle Aspiration and PD-L1 Yields. Lung. 2024. doi:10.1007/s00408-024-00692-4

BibTeX
@article{Khoury2024,
  author = {Khoury, Lara M and Sheehan, Kristin N and Mariencheck, William I and Gershner, Katherine A and Maslonka, Matthew and Niehaus, Angela G and Isom, Scott and Bellinger, Christina R},
  title = {Endobronchial Ultrasound Guided Transbronchial Needle Aspiration and PD-L1 Yields},
  journal = {Lung},
  year = {2024},
  doi = {10.1007/s00408-024-00692-4}
}
Kostenlos starten →